関連する実験動画
Updated: Jun 24, 2026
16:24
Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
核ホルモン受容体のマイクロRNAの調節は,発達進行を制御する
Axel Bethke1, Nicole Fielenbach, Zhu Wang
1Huffington Center on Aging, Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
Science (New York, N.Y.)
|April 4, 2009
まとめ
核受容体とマイクロRNAは,発達中の遺伝子発現を制御する. この研究は,核受容体DAF-12が,ホルモンへの反応として,発達段階間の移行に分子スイッチとしてマイクロRNAを使用する方法を示しています.
科学分野:
- 発達生物学 発達生物学とは
- 分子内分泌学 分子内分泌学
- 遺伝子規制 遺伝子規制
背景:
- 核受容体 (NRs) は,レチノイドやステロイドなどの小分子に反応して遺伝子発現を調節し,組織発育を制御します.
- マイクロRNA (miRNA) は,遺伝子発現を転写後に調節する小さなノンコーディングRNAであり,発育と疾患において極めて重要です.
研究 の 目的:
- マイクロRNA発現の調節におけるCaenorhabditis elegans核受容体 DAF-12の役割を調査する.
- DAF-12とそのリガンドがマイクロRNAを介して発達移行を制御するメカニズムを解明する.
主な方法:
- Caenorhabditis elegansの核受容体 DAF-12とそのステロイドリンガンドの分析.
- let-7マイクロRNAファミリープロモーターの活性化を研究した.
- マイクロRNAの標的遺伝子であるhbl-1のダウンレギュレーションとその細胞分裂パターンへの影響について研究した.
主要な成果:
- 核受容体DAF-12は,ステロイドリガンドと結合すると,let-7マイクロRNAファミリーのプロモーターを直接活性化します.
- この活性化は,表皮幹細胞の進行に関与するマイクロRNA標的hbl-1のダウン調節につながります.
- リガンドがない場合,DAF-12はマイクロRNA発現を抑制し,発達停止と相関する.
結論:
- マイクロRNAは,ホルモン結合分子スイッチの構成要素として機能する.
- このスイッチメカニズムは,以前の開発プログラムの終了を可能にし,後の開発プログラムの開始を可能にします.
- 核ホルモンのシグナル伝達とマイクロRNA媒介による発達タイミングを結びつける新しい調節経路を特定した.
関連する概念動画
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:45Regulation of Nuclear Protein Sorting
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
01:23Regulation of Expression at Multiple Steps
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...
01:31Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes: